Andelyn Biosciences’ Post

View organization page for Andelyn Biosciences, graphic

8,032 followers

Andelyn Biosciences is honored to have been selected by UMass Chan Medical School to manufacture clinical grade AAV9-CSA vector to treat Cockayne syndrome. UMass Chan Medical School has received $2.2 million from nonprofit patient-advocacy organization Riaan Research Initiative to bring the start of clinical trials for the fatal autosomal recessive disorder one step closer. Cockayne syndrome is a complex and lethal multi-system genetic disorder. It causes a failure in the body's DNA transcription and repair processes. https://lnkd.in/eHNct6uv #andelynbiosciences #genetherapy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics